Ondiano, Cresencia C.
HRN: 22-58-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2023
LEVOFLOXACIN 500MG (TAB)
02/12/2023
02/18/2023
PO
500mg
Od
Cap Mr; Ba Not In Ae
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes